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OPEN
ORIGINAL ARTICLE
Genetic overlap between type 2 diabetes and depression in
Swedish and Danish twin registries
C Kan1, NL Pedersen2, K Christensen3,4, SR Bornstein5,6, J Licinio7,8, JH MacCabe1, K Ismail1,5,9 and F Rijsdijk1,9
A bidirectional association between type 2 diabetes (T2DM) and depression has been consistently reported. Depression is
associated with worse biomedical outcomes and increased mortality. The mechanisms underlying the association of T2DM with
depression remain unclear. One possible question we can address is the extent to which the co-occurrence of diabetes and
depression is due to correlated genetic and/or environmental risk factors. In this study, we performed structural equation model
ﬁtting to population-level data from the Swedish (n= 68 606) and Danish (n= 95 403) twin registries. The primary outcomes were
clinical diagnosis of T2DM and depression using national hospital discharge registries. The phenotypic correlation between T2DM
and depression is modest in both samples. In the Swedish sample, unique environmental effects explain a greater proportion of the
covariance in males, whereas the association is primarily attributed to genetic effects in females. In the Danish sample, genetic
effects account for the majority of the covariance in both males and females. Qualitative genetic sex differences are observed in
both samples. We believe this is the ﬁrst study to demonstrate signiﬁcant genetic overlap between T2DM and depression.
Molecular Psychiatry advance online publication, 29 March 2016; doi:10.1038/mp.2016.28
INTRODUCTION
Cross-sectional and longitudinal studies have consistently
reported an association between type 2 diabetes (T2DM) and
depression,1,2 with up to 60% increased risk for developing T2DM
in individuals with depression and 15% increased risk for incident
depression in those with T2DM.3,4 Depression has been associated
with adverse effects on diabetes outcomes including suboptimal
glycaemic control, complications and higher rates of mortality.
Tentative evidence suggests a common biological pathway
between T2DM and depression, as people with depression have
increased levels of inﬂammation, hyperactivity in the hypotha-
lamic–pituitary adrenal axis and sympathetic nervous system.5
Those biological processes also underlie T2DM.6
A signiﬁcant genetic correlation between T2DM and depression
would provide evidence in support of a common genetic pathway
to both disorders. Although it is known that genetic factors are
aetiologically important in both T2DM and depression, it is unclear
to what extent the T2DM-depression association correlated
genetic or environmental factors. Twin studies provide a valuable
approach to investigate genetic inﬂuences on complex traits or
disorders,7 as well as the genetic architecture of comorbidity.
They use the similarity within and between diseases across
monozygotic (MZ) and dizygotic (DZ) twins to estimate the
relative importance of the effects of genetic, shared and
individual-speciﬁc environmental factors on the variance and
covariance of the disorders.
Two twin studies have addressed the genetic comorbidity of
T2DM and depression. The Vietnam Era Twin Study of Aging
reported a signiﬁcant odd ratio between T2DM and depression
(1.7 (95% conﬁdence interval: 1.1–2.7)) in a sample restricted to
males aged 50–59. They concluded that there was no signiﬁcant
genetic correlation (0.19 (0–0.46)) or unique environmental
correlation (0.09 (0–0.45)) between T2DM and depression.8
A study based on the Screening Across the Lifespan Twin (SALT)
study reported a signiﬁcant phenotypic correlation (0.20
(0.09–0.33)) in combined analyses of male and female twins aged
40 years and older. They concluded that there was signiﬁcant
environmental correlation (0.54 (0.02–0.88)) between T2DM and
depression.9
Although current evidence does not support a common genetic
pathway hypothesis, a genetic model that incorporates possible
quantitative and qualitative sex differences in genetic and
environmental effects is called for, given the substantially higher
prevalence rate of comorbid T2DM and depression in females
compared with males.10–12 We therefore aimed to examine the
genetic aetiology of the T2DM-depression association in two large
population samples of twins using sex-limitation genetic model-
ling. In this study we combined the data from the Swedish and
Danish twin registries, as they have a similar ethnic population
structure.
MATERIALS AND METHODS
Sample
The Swedish Twin Registry (http://ki.se/twinreg) covers over 99% of all
twins born in Sweden between 1886 and 2000 (~160 000 individuals).13
This study will include data from the following two cohorts: (i) SALT
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(n= 44 113) and (ii) Swedish Twin Studies of Adults: Genes and
Environment (STAGE; n= 24 493). The SALT cohort consists of twins born
between 1886 and 1958,13,14 whereas the STAGE cohort consists of twins
born between 1959 and 1985.15 The project was approved by the Regional
Research Ethics Board at Karolinska Institute and the Steering Board of the
Swedish Twin Registry.
The Danish Twins Registry covers twin births in Denmark since 1870,
with 170 000 individuals registered as of January 2011.16 This study
will include all birth cohorts (1870–1930, 1931–1952, 1952–1982 and
1983–2000), excluding participants aged o18 at time of data retrieval. The
project was approved by the Danish Data Protection Agency.
Primary variables from hospital registry records
The Swedish National Patient Registry has coverage of inpatient care for
medical and psychiatric disorders since 1963 on a regional basis, extended
to complete coverage in 1987 and further expanded to include outpatient
care in 2001. Disorders were coded according to the International
Classiﬁcation of Disease (ICD) 8th, 9th or 10th Editions. The Swedish Twin
Registry is linked to the National Patient Registry using a unique personal
registration number assigned to all residents of Sweden. Data were
extracted from 1969 to 31 December 2010.
The Danish National Patient Register initially had coverage of
inpatient care for somatic disorders in 1977, and extended to complete
coverage of all inpatient and outpatient care for medical and psychiatric
disorders since 1995.17 Disorders were coded according to the ICD 8th or
10th Editions. The Danish Twin Registry is linked to the National Patient
Registry using a unique personal identiﬁcation number recorded in
the Danish Civil Registration System. Data were extracted from 1977 to
1 April 2011.
The primary outcomes are ICD diagnoses of T2DM and depression from
the respective National Hospital Discharge Registry, deﬁned a prior to
maximise statistical power. T2DM is deﬁned by the following codes:
(i) ICD-8: 250; (ii) ICD-9: 250.00, 250.02, 250.10, 250.12, 250.20, 250.22,
250.30, 250.32, 250.40, 250.42, 250.50, 250.52, 250.60, 250.62, 250.70,
250.72, 250.80, 250.82, 250.90, 250.92 and (iii) ICD-10: E11. Depression is
deﬁned by the following codes: (i) ICD-8: 296.0, 296.2, 296.9, 298.0, 300.4;
(ii) ICD-9: 296.2, 296.3, 300.4, 301.10, 301.12, 301.13, 309.10, 311 and (iii)
ICD-10: F32, F33, F34.1 and F38.1 (Supplementary Table 1).
Secondary variables
Zygosity of same-sex twin pairs was based on standard self-report items
and, when validated with biological makers, has an accuracy of 95–99% in
the Swedish Twin Registry18 and 96% in the Danish Twin Registry.19
Demographic details included age and sex. The demographic data were
retrieved on 31 December 2010 for the Swedish twin sample and 11
October 2014 for the Danish twin sample.
Statistical analysis
Genetic model ﬁtting. The classical twin method is based on comparison
of MZ twins who share 100%, whereas DZ twins share on average 50% of
segregating genes. In the univariate ACE model, individual differences in a
trait are assumed to arise from: (i) additive genetic inﬂuences (A), (ii) shared
environmental inﬂuences (C) and (iii) unique environmental inﬂuences (E).
In bivariate twin analysis, in addition to the variance components of the
individual traits, the main goal is to decompose the phenotypic correlation
between them into parts due to correlating addictive genetic (rA), shared
environmental (rC) and unique environmental (rE) effects predisposing to
both traits.7 Quantitative sex differences are modelled by specifying
sex-speciﬁc ACE paths for T2DM and depression as well as rA, rC and rE.20
The power is derived from different MZ-DZ correlation ratios across sex.
Qualitative sex differences are incorporated by specifying free correlational
paths between (i) all male and female genetic factors or (ii) all male and
female common environmental factors in DZ opposite-sex twin pairs. The
power is derived from differential within-trait and cross-trait correlations in
opposite-sex compared with same-sex DZ pairs.20
Genetic model ﬁtting analysis was performed in the programme
OpenMx.21 A liability threshold model was used, assuming that the risk
to T2DM and depression is each normally distributed in the general
population with the disorder manifesting when a certain threshold of risk
is exceeded.22 Their joint distribution is assumed to have a bivariate
normal distribution, with the relative proportions of concordant (both
twins above or below the thresholds) and discordant pairs informing on
the correlation between the liabilities. Given the range of birth year from
1896 to 1985 in the Swedish Twin Registry and from 1870 to 2000 in the
Danish Twin Registry, age at the time when the demographic data were
retrieved was modelled as a covariate on the thresholds.
Two criteria were used to choose the best-ﬁtting, parsimonious model:
(i) differences in minus twice the log-likelihood (−2LL) yielding a statistic
equivalent to a χ2-test, with degrees of freedom equal to the difference in
the numbers of parameters and (ii) Akaike’s Information Criterion (AIC),23
with lower values indicating a better balance between explanatory power
and parsimony. A difference in AIC at least 10 indicates substantial support
in favour of the more parsimonious model.
Secondary analysis. The genetic model ﬁtting analysis was repeated and
restricted to individuals born after 1950 in both the Swedish and Danish
samples.
RESULTS
Descriptive ﬁnding
The Swedish Twin Registry from the SALT and STAGE cohorts
consists of 68 606 twin individuals with known age, sex,
zygosity, T2DM and depression. This results in 50 082 twin
pairs and 18 524 single twins (Table 1). The mean age was 58.5
(17.6) as of 31 December 2010 when the demographic data were
retrieved.
The Danish Twin Registry consists of 115 886 twin individuals, of
whom 95 403 individuals have known age, sex, zygosity, T2DM
and depression status and are aged over 18. This results in 94 194
twin pairs and 1209 single twins (Table 1). The mean age was 60.0
(16.8) as of 11 October 2014 when the demographic data were
retrieved.
In both the Swedish and Danish samples, the prevalence rates
for T2DM and depression were similar for males and females
(Table 1). Mean-centred age was incorporated as a covariate,
and thus, the thresholds and other estimates apply to a sample at
mean age. To illustrate, the prevalence rate for T2DM in males for
the Swedish sample is 4.7% (z-value = 1.67) at age 59. With the
effect of age being estimated at –0.03, T2DM prevalence rates will
be 1.3% at age 40 (z-value = 2.24) and 9.0% at age 70
(z-value = 1.34).
Logistic regression analysis revealed a positive relationship
between T2DM and depression in males and females in the
Swedish (Rph: males 0.13 (0.08–0.14); females 0.16 (0.12–0.17) and
Danish (Rph: males 0.16 (0.12–0.20); females 0.15 (0.12–0.20))
samples. Tetrachoric correlations stratiﬁed by zygosity and sex are
summarised in Supplementary Table 2.
Genetic model ﬁtting in the Swedish twin sample
The starting point was an ACE model that included both
quantitative and qualitative sex differences in genetic factors (model
IS: − 2LL=52 061.97; df= 137 186; AIC=− 222 310). The effect of
common environment was negligible, shown by a non-signiﬁcant
decline in ﬁt of the AE model (model 2S: −2LL=52 063.00;
df = 137 192; AIC=− 222 321; χ2 = 1.04; P= 0.98). To test the
signiﬁcance of qualitative sex differences, all genetic factors were
constrained to correlate at 0.50 across males and females in
opposite-sex pairs model, resulting in a signiﬁcantly poorer ﬁt
of the AE model (model 3S: − 2LL=52 116.61; df= 137 196;
AIC=− 222 275; χ2 = 53.61; Po0.05). All A and E paths are therefore
estimated freely for males and females with no further constraints,
as it was not possible to equate them without a signiﬁcant
worsening of ﬁt.
The best-ﬁtting model is therefore the full sex-limitation
bivariate AE model (Figure 1), with both quantitative and
qualitative sex differences. The heritability estimates for clinical
diagnoses of T2DM and depression were 66% (58–73%) and 45%
(32–56%) in males and 71% (65–77%) and 38% (30–47%) in
females, respectively. The genetic correlation between T2DM and
depression was non-signiﬁcant in males (0.06 (−0.13–0.25)) but
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signiﬁcant in females (0.23 (0.07–0.38)). In males, the phenotypic
correlation between T2DM and depression was 31% due to
genetic factors and 69% due to individual-speciﬁc environmental
factors, whereas in females, these values were 75% and 25%,
respectively.
Under the assumption of random mating, all correlations
between genetic factors are expected to be 0.50 in same-sex DZ
sibling pairs.24 The estimated correlation between male and
female genetic factors for T2DM (ADMM and ADMF) was 0.38
(0.28–0.49) and for depression (ADM and ADF) is 0.47 (0.25–0.50;
Figure 1). They are close to the expected value of 0.50, suggesting
little or no qualitative sex difference within diabetes and
depression, respectively. The estimated correlations between the
genetic factors for (i) male T2DM and female depression (ADMM
and ADF) and (ii) male depression and female T2DM (ADM and
ADMF) were − 0.03 (−0.21–0.14) and 0.09 (0.07–0.10), respectively.
They are substantially different from 0.50, indicating that different
genetic factors are at play in males and females when it comes
to explaining the T2DM-depression association (qualitative sex
difference).
Genetic model ﬁtting in the Danish twin sample
The same approach was adopted in the Danish sample. The starting
model was the ACE model with both quantitative and qualitative
sex differences in genetic factors (model ID: − 2LL=58 776.30;
df = 176 878; AIC =− 294 979.7). The effect of common environment
was again negligible, as shown by a non-signiﬁcantly decline in ﬁt
(model 2D: − 2LL= 58 778.83; df = 176 884; AIC=− 294 989.2;
χ2 = 2.52; P= 0.87). The effect of qualitative sex difference was
important, as when all genetic factors were constrained to correlate
at 0.50 across males and females in the opposite-sex pair model, a
signiﬁcantly poorer ﬁt of the AE model resulted (model 3D:
− 2LL= 58 838.40; df = 176 888; AIC=− 294 937.6; χ2 = 62.10;
Po0.05). All A and E paths are therefore estimated freely for
males and females with no further constraints.
The best-ﬁtting model is also the full sex-limitation bivariate AE
model (Figure 2), with both quantitative and qualitative sex
differences. The heritability estimates for clinical diagnoses of
T2DM and depression were 67% (61–73%) and 45% (35–54%) in
males and 66% (59–72%) and 53% (46–59%) in females,
respectively. In both males and females, the genetic correlation
between T2DM and depression was moderate and signiﬁcant
(males: 0.25 (0.23–0.41); females: 0.18 (0.06–0.31)). The phenotypic
correlation was primarily attributed to shared genetic effects in
both sexes (males: 87%; females: 74%).
The estimated correlation between male and female genetic
factors for T2DM (ADMM and ADMF) was 0.42 (0.31–0.50) and for
depression (ADM and ADF) was 0.40 (0.26–0.50; Figure 1). They are
close to the expected value of 0.50, suggesting little or no
qualitative sex difference within diabetes and depression,
respectively. The estimated correlations between the genetic
factors for (i) male T2DM and female depression (ADMM and ADF)
and (ii) male depression and female T2DM (ADM and ADMF) were
Table 1. Descriptive summary of MZ and DZ twins in Swedish and Danish twin samples, stratiﬁed by sex
Sample Swedish Danish
Males Females Males Females
Number of paired twins
Number of single twins
MZ 6524
2335
9270
2131
11 006
59
11 110
59
DZ 7440
3757
9770
3421
19 538
130
17 640
113
Opposite-sex 17 078
6880
34 900
848
Total 50 082
18 524
94 194
1209
Age, mean (s.d.) MZ 54.9 (17.9) 55.0 (18.7) 58.3 (16.8) 59.5 (18.3)
DZ 60.3 (16.8) 61.3 (18.0) 60.5 (16.1) 63.0 (17.7)
Opposite-sex 59.2 (16.5) 58.6 (15.7)
Total 58.5 (17.6) 60.0 (16.8)
Prevalence of T2DM (%)a MZ 5.5 4.2 4.1 3.3
DZ 6.9 5.2 4.7 4.2
Opposite-sex 5.8 3.1
Prevalence of depression (%)a MZ 3.7 5.8 2.8 4.7
DZ 3.7 5.7 3.2 5.7
Opposite-sex 4.9 3.8
Proband wise concordance rate for T2DM
(Number of concordant pair, discordant pair)
MZ 0.42
(69, 190)
0.43
(75, 195)
0.37
(83, 287)
0.33
(60, 247)
DZ 0.20
(49, 398)
0.23
(53, 350)
0.14
(64, 764)
0.18
(66, 605)
Opposite-sex 0.18
(91, 813)
0.13
(66, 886)
Proband wise concordance rate for depression
(Number of concordant pair, discordant pair)
MZ 0.21
(22,174)
0.22
(57, 399)
0.19
(29, 243)
0.23
(59, 400)
DZ 0.06
(8, 249)
0.05
(13, 489)
0.05
(16, 591)
0.16
(77, 837)
Opposite-sex 0.09
(37, 706)
0.09
(61, 1170)
Abbreviations: DZ, dizygotic twins; MZ, monozygotic twins; T2DM, type 2 diabetes. aIn the genetic modelling, the thresholds and other estimates apply to the
sample at mean age. For example, with the effect of age being estimated at − 0.03 for males in the Swedish Twin Registry, T2DM prevalence rates will be 1.3%
at age 40 and 9.0% at age 70.
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0.19 (0.07–0.25) and − 0.06 (−0.25–0.13), respectively. These are
substantially different from 0.50, indicating that different genetic
factors are involved in explaining the T2DM-depression associa-
tion across sex (qualitative sex difference).
Secondary analysis
In samples restricted to individuals born after 1950, the best-ﬁtting
model is also the full sex-limitation bivariate AE model in both
the Swedish and Danish samples, with both quantitative and
qualitative sex differences (data not shown). In the Swedish
sample, the phenotypic correlation between T2DM and depres-
sion was signiﬁcant in both males (0.21 (0.13–0.30)) and females
(0.25 (0.17–0.33)). The heritability estimates for T2DM and
depression were 73% (58–81%) and 52% (50–67%) in males and
72% (58–84%) and 40% (30–49%) in females, respectively. The
genetic correlation between T2DM and depression was signiﬁcant
for females (males: 0.00 (−0.24–0.32); females: 0.49 (0.26–0.73)).
Figure 2. Parameters estimates from bivariate AE twin models for type 2 diabetes and depression, using the Danish twin sample, with age as a
covariate. Best-ﬁt full sex-limitation bivariate AE model ﬁt to Danish data in opposite-sex dizygotic twins. Asterisk indicates a signiﬁcant
pathway. A indicates addictive genetic effects; E for unique environmental effects; subscript DM for type 2 diabetes; subscript D for depression
DM; M for males and F for females. Additive genetic and unique environment contributions to type 2 diabetes and depression are indicated
by ADMM, ADM, EDMM and EDM in males, and by ADMF, ADF, EDMF and EDF in females, respectively.
Figure 1. Parameters estimates from bivariate AE twin models for type 2 diabetes and depression, using the Swedish twin sample, with age as
a covariate. Best-ﬁt full sex-limitation bivariate AE model ﬁt to Swedish data in opposite-sex dizygotic twins. Asterisk indicates a signiﬁcant
pathway. A indicates addictive genetic effects; E for unique environmental effects; subscript DM for type 2 diabetes; subscript D for depression
DM; M for males and F for females. Additive genetic and unique environment contributions to type 2 diabetes and depression are indicated
by ADMM, ADM, EDMM and EDM in males, and by ADMF, ADF, EDMF and EDF in females, respectively.
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There is no major difference between the ﬁndings from the
primary and secondary analysis.
In the Danish sample, the phenotypic correlation between
T2DM and depression was signiﬁcant in both males (0.11
(0.02–0.19)) and females (0.13 (0.04–0.22)). The heritability
estimates for T2DM and depression were 78% (67–85%) and
45% (31–58%) in males and 78% (62–89%) and 47% (36–57%) in
females, respectively. The genetic correlation between T2DM and
depression was no longer signiﬁcant (males: 0.07 (−0.18–0.32);
females: 0.21 (−0.06–0.47)), in comparison with the primary
analysis, as the 95% conﬁdence intervals cross zero.
DISCUSSION
To the best of our knowledge, this is the ﬁrst study to examine the
genetic aetiology of the T2DM-depression comorbidity using
hospital registry data from two large population samples of male
and female twins covering the entire adult age range. The most
notable feature of our ﬁnding is the similarity between the results
from the Swedish and Danish samples. Both samples support the
notion that qualitative genetic sex differences are at play in the
genetic overlap between T2DM and depression. The main
difference is the proportion of the T2DM-depression association
due to shared genetic factors between Swedish and Danish
samples. In the Swedish sample, the phenotypic relationship is
mainly due to unique environment factors in males and shared
genetic factors in females. In the Danish sample, it is due to shared
genetic effects in both sexes. The observations were attenuated in
the analyses restricted to individuals born after 1950. Although
this could be a genuine difference, the 95% conﬁdence intervals
around the genetic correlations are overlapping between the
primary and secondary analyses. In addition, the secondary
analysis is half of the initial sample size for the Swedish sample
(primary analysis: n = 68 606; secondary analysis: n = 35 912) and
two ﬁfths for the Danish sample (primary analysis: n= 95 403;
secondary analysis: n = 40 984), leading to reduced power. The
secondary analysis further strengthens the validity of our primary
ﬁndings, as any observed cohort effect may potentially be
secondary to multiple residual confounders. The ﬁndings, how-
ever, did not differ signiﬁcantly between the entire sample and
those born after 1950, especially in the Swedish sample.
Previous literature
Our results differ from previous ﬁndings. The Vietnam Era Twins
Study of Aging8 suggests that there is no evidence of common
genetic factors in contributing to the T2DM-depression associa-
tion. The ﬁnding is difﬁcult to interpret as it was restricted to
males aged 50–59, relied on a much smaller sample and used
self-reported data to construct the diagnosis of T2DM and
depression.
The SALT study (using a cohort subsample included in our
Swedish sample) previously reported a signiﬁcant contribution
of unique environmental factors in the T2DM-depression
association, but insigniﬁcant contribution of genetic factors.9
Discrepancies in results could be due to reduced power, narrower
age range and the use of computerised interview-based
Composite International Diagnostic Inventory-Short Form instead
of hospital registry data.
Implication
This is the ﬁrst study examining genetic overlap in the T2DM-
depression comorbidity in two large, population-based twin
registries. Our ﬁnding of qualitative genetic sex differences
implies that although the comorbidity is mainly due to correlated
genetic risk factors, these factors are not necessarily the same
in males and females. Possible biological support for this
observed latent effect is given by ﬁndings regarding the activation
of the hypothalamic–pituitary adrenal axis, which has been
postulated to have a major role in the T2DM and depression
comorbidity.25 A preliminary study reported sex difference
between hypothalamic–pituitary adrenal axis activity and adre-
nergic polymorphisms in 189 patients with depression.26
Increased hypothalamic–pituitary adrenal axis activity was asso-
ciated with the ADRA2A genotype in males and ADRB2 genotype
in females.
Other support for the observed qualitative sex differences in
comorbidity is given by ﬁndings regarding visceral obesity, which
has been suggested as a biological explanatory link between
T2DM and depression comorbidity.25,27 Anthropometric traits such
as waist-to-hip ratio are well-established proxy measures of
abdominal fat distribution.28,29 Sex-speciﬁc dimorphic genetic
effects have been reported for waist-to-hip ratios.30 Of particular
interest, a female-only association was reported for the peroxi-
some proliferator-activated receptors region.31 Proliferator-
activated receptors-γ has a well-established role in T2DM
treatment and has been implicated in its pathology.32 It has also
been postulated as a potential target for the treatment of
depression, as it is closely related to parainﬂammation and
endoplasmic reticulum stress, processes that can potentially
interfere with normal stress response in a depressive illness.33,34
Interestingly, the glucocorticoid receptor gene have been
linked to both T2DM35 and depression,36 and its polymorphism
has been associated with β-cell function in females, but not in
males.37
The ﬁndings from this study have potential clinical relevance.
Our study demonstrates that the T2DM-depression comorbidity
may be genetic in origin, with different genetic factors being at
play in males and females. Future research would involve
developing sex-speciﬁc biopsychosocial explanatory models and
conducting sex-speciﬁc analysis in molecular genetic studies.
Understanding the underlying mechanism of the T2DM and
depression comorbidity will provide useful insight into identifying
potential biological mechanisms that may be accessible to
interventions.
Limitations
Our ﬁndings should be interpreted in the context of potentially
signiﬁcant limitations. No discrimination of types of diabetes was
made in ICD-8 (1965) and the loss of participants at the time of
retrieval of hospital registry data (2010 for the Swedish Twin
Registry and 2011 for the Danish Twin Registry) may lead to
misclassiﬁcation of diabetes type. This is probably modest, given
that T2DM comprises 90% of adults with diabetes.38 Estimations
obtained from a single database should, however, be interpreted
with caution.39 In addition, the mean age of onset for T2DM has
been reported to be 46-year old40 and we have included all
individuals aged over 18 in both samples. It is therefore possible
that individuals without a diagnosis of T2DM still have the
propensity to develop the illness.
Another important limitation of our study is the use of national
health registries. The Swedish and Danish National Hospital
Discharge Registries do not include visits to general practitioners
and have been shown to capture more severe cases.41 Our
constructs of T2DM and depression might therefore capture a
more severe spectrum of the disorders that warrant outpatient
care and/or hospital admission. In addition, there is a small
possibility of misclassiﬁcations of cases as controls, such as when a
participant had a past history of depression before the inception
of the registry and did not subsequently have further episodes of
depression requiring outpatient or inpatient care.
Studies have also shown that males were less likely to seek
help.42 The prevalence rates for diabetes and depression were
similar across the sexes (Table 1). Anthropometric traits such as
body mass index have not been adjusted for in this study and
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we need to note the limitation that the observed genetic overlap
can in part be due to the respective correlation of these traits
with T2DM43 and depression.44 This and previous studies on T2DM
and depression have focused on European-descent samples
and replication in Asian and African descent populations are
needed.
CONCLUSION
This study uses two large, independent population-based twin
samples to explore the genetic overlap between T2DM and
depression. Our results suggest a genetic aetiology to the T2DM-
depression comorbidity in males and females. It further suggests
that different genetic risk factors may be involved in this
comorbidity in males and females. T2DM and depression are
chronic conditions with major public health impact. Under-
standing the pathophysiology of the T2DM and depression
comorbidity, the basis for possible including sex differences, is
critical for developing appropriate and effective interventions for
this complex patient group.
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